Page last updated: 2024-08-24

cephalosporin c and Cystic Fibrosis of Pancreas

cephalosporin c has been researched along with Cystic Fibrosis of Pancreas in 130 studies

Research

Studies (130)

Timeframe	Studies, this research(%)	All Research%
pre-1990	34 (26.15)	18.7374
1990's	21 (16.15)	18.2507
2000's	27 (20.77)	29.6817
2010's	27 (20.77)	24.3611
2020's	21 (16.15)	2.80

Authors

Authors	Studies
Esquivel, MD; Finklea, JD; Monogue, ML; Sanders, JM; Smith, GS	1
Albarracín Orio, AG; Bonomo, RA; Colque, CA; Dotta, G; Feliziani, S; Hedemann, LG; Hickman, RA; K Johansen, H; Molin, S; Moreno, DM; Moyano, AJ; Smania, AM; Sommer, LM; Tomatis, PE; Vila, AJ	1
Campo, RD; Cantón, R; Castillo, MG; de Dios Caballero, J; Gomis-Font, MA; López-Causapé, C; Maruri-Aransolo, A; Mulet, X; Oliver, A; Penev, I	1
Böhringer, N; Horst, J; Hübner, J; Kappler, M; Kolberg, L; Kresna, IDM; Liu, Y; Marner, M; Mettal, U; Meyer-Bühn, M; Mihajlovic, S; Schäberle, TF; von Both, U; Wang, L	1
Faurholt-Jepsen, D; Jensen, PØ; Johansen, HK; Katzenstein, TL; Kolpen, M; Pressler, T; Qvist, T	1
Abbott, IJ; Chang, CC; Dennison, A; Kostoulias, X; Peleg, AY; Spelman, DW; Wisniewski, J; Zisis, H	1
Epps, KL; Epps, QJ; Young, DC; Zobell, JT	1
Allan, RN; Cai, Y; Connett, GJ; Davies, JC; Faust, SN; Feelisch, M; Howlin, RP; Kelso, MJ; Rineh, A; Silva, DG; Soren, O; Webb, JS	1
Azamifar, F; Blaskovich, MAT; Cheung, CY; Christodoulides, M; Cook, GM; Cooper, MA; Dolange, V; Elliott, AG; Faust, SN; Kelso, MJ; McEwan, T; Naimi-Jamal, MR; Poh, WH; Ravikumar, V; Rice, SA; Rineh, A; Soren, O; Webb, JS; Zuegg, J	1
Ang, JY; Arrieta, AC; Feng, EH; Johnson, MG; Larson, KB; Rhee, EG; Rizk, ML; Yu, B; Zhang, Z	1
Biswas, B; Bivens, BN; Brown, DE; Brownstein, MJ; Burch, AK; Daniels, R; Fackler, J; Gainey, AB; Horne, B; Malagon, F	1
Benner, K; Branstetter, J; Crowder, C; Searcy, H; Troxler, B; Yarbrough, A	1
Davis, JJ; Hernandez, RE; Hoffman, LR; Long, SW; Roch, M; Rosato, AE; Rosato, RR; Rose, WE; Saavedra, MO; Taglialegna, A; Varela, MC	1
Cohen, L; Finklea, JD; Jain, R; Nolan, PJ; Smith, TT	1
Alby, K; Alexander, J; Bartelt, LA; Brown, DE; Brownstein, MJ; Burch, AK; Carr, AL; Cheema, F; Daniels, R; Gainey, AB; Jones, MB; Lachiewicz, AM; Linder, KE; Longworth, S; Miller, MB; Shields, RK; Tompkins, KM; van Duin, D; Warner, NC	1
Epps, KL; Epps, QJ; Zobell, JT	1
Baccani, I; Bartalesi, F; Bartoloni, A; Borchi, B; Bresci, S; Cavallo, A; Ottino, L; Rossolini, GM	1
Cooper, K; Gould, IM; Hijazi, K; Ironside, C; Okoliegbe, IN	1
Anstey, KM; Choi, L; Dawson, D; Kleinhenz, ME; Otani, IM	1
Holland, P; Jahnke, N	1
Belcher, R; Zobell, JT	1
LeCleir, LK; Pettit, RS	1
Epps, KL; Young, DC; Zobell, JT	1
Bellon, N; Ben Mansour, A; de Blic, J; Frassati-Biaggi, A; Lezmi, G; Ponvert, C; Sermet-Gaudelus, I	1
Barsky, EE; Goobie, SM; McAdam, AJ; Pereira, LM; Priebe, GP; Sawicki, GS; Sullivan, KJ; Wong, A	1
Blasi, F; Downey, DG; Elborn, JS; Gramegna, A; Millar, BC; Moore, JE	1
Finklea, JD; Hollaway, R; Jain, R; Le, J; Lee, F; Lowe, K	1
Jones, AL; Lee, AC	1
De Wachter, E; Echahidi, F; Herpol, M; Peeters, C; Piérard, D; Van Dalem, A; Vandamme, P; Wybo, I	1
Floch, P; Gaudru, C; Guet-Revillet, H; Massip, C; Mathieu, C; Miaut, V; Oswald, E; Segonds, C	1
Di Bonaventura, G; Fiscarelli, E; Gherardi, G; Linardos, G; Pompilio, A	1
Aitken, E; Gould, IM; Hijazi, K; Joshi, C; Oggioni, MR; Zamudio, R	1
Baklouti, S; Concordet, D; Gandia, P; Guet-Revillet, H; Mane, C; Massip, C; Murris, M	1
Ann Justo, J; Bookstaver, PB; Elizabeth Davis, S; Foster, R; Gould, A; Ham, J; Hucks, J; Nicolau, DP	1
Elphick, HE; Jahnke, N	1
Cernoch, PL; Long, SW; Mehta, SC; Musick, WL; Musser, JM; Olsen, RJ; Palzkill, T; Perez, KK; Rosato, AE	1
Anstead, MI; Autry, EB; Burgess, DR; Gardner, BM; Kuhn, RJ; Leung, NR; Rybak, JM	1
Biek, D; Bradley, JS; Cannavino, CR; Critchley, IA; Farrell, DJ; Jones, RN; Le, J; Mendes, RE; Sader, HS; Skochko, SM	1
McClain, D; Vickery, SB; Wargo, KA	1
Cies, JJ; Kuti, JL; Monogue, ML; Muhlebach, M; Nicolau, DP; Pettit, RS	1
Chalhoub, H; Denis, O; Deplano, A; Elborn, JS; Kahl, BC; Mustafa, MH; Rodriguez-Villalobos, H; Traore, H; Tulkens, PM; Tunney, MM; Van Bambeke, F; Vanderbist, F; Vergison, A	1
Elphick, HE; Scott, A	1
Compain, F; Grohs, P; Kaibi, I; Lavollay, M; Mainardi, JL; Morand, P; Podglajen, I; Taieb, G	1
Hauber, HP; Mack, D; Pforte, A; Schulz, M; Schumacher, U; Zabel, P	1
Juan, C; Maciá, MD; Mena, A; Mulet, X; Oliver, A; Pérez, JL	1
Falkiner, FR; Fitzgerald, MX; Keane, CT; Kelly, N; Murphy, M	1
Cantón, R; Fernández-Olmos, A; Ge, Y; Juan, C; Oliver, A; Zamorano, L	1
Elborn, JS; Parkins, MD	1
Davis, GA; Feola, DJ; Hayes, D; Kuhn, RJ; Murphy, BS	1
Bulitta, JB; Holzgrabe, U; Kinzig, M; Landersdorfer, CB; Sörgel, F; Stephan, U	1
Ampofo, K; Sherwin, CM; Spigarelli, MG; Stockmann, C; Waters, CD; Young, DC; Zobell, JT	1
Jones, RN; Mutnick, AH; Turner, PJ	1
Chanteux, H; Mingeot-Leclercq, MP; Servais, H; Tulkens, PM; Viaene, E	1
Baririan, N; Chanteux, H; Servais, H; Tulkens, PM; Viaene, E	1
Adriensen, B; Husson, MO; Loiez, C; Massoni-Cristante, S	1
Bernard, E; Breilh, D; Bru, JP; Chiche, D; Dujardin, I; Garraffo, R; Goldstein, F; Lavrard, I; Potel, G	1
Kadry, AA	1
Conway, SP; Denton, M; Nadesalingam, K	1
Elphick, HE; Tan, A	2
Alvarez, A; Baquero, F; Cantón, R; Cobos, N; de Gracia, J; García-Quetglas, E; Gartner, S; Honorato, J; Oliver, A; Salcedo, A	1
Dubovik, LG; Kolbatova, ES; Polikarpova, SV; Postnikov, SS; Semykin, SIu	1
Beringer, PM; Falck, P; Gill, M; Han, EE; Louie, S; Rao, P; Shapiro, B	1
Neu, HC; Prince, AS	2
Butzler, JP; Dab, I; Gordts, B	1
Fitzpatrick, SB; Rosenstein, BJ	1
Agostini, M; Barlocco, G; Bonomi, U; Borgo, G; Bozzino, L; Cabrini, G; Cappelletti, LM; Castellani, L; Conforti, M; Mastella, G	1
Assael, BM; Brienza, A; Crossignani, RM; Giunta, A; Granata, F; Lodi, G; Padoan, R; Passarella, E; Vallaperta, PA; Xerri, L	1
Bint, AJ; Constable, FL; Constable, J; Patton, KR	1
Alfredson, H; Ericsson, A; Malmborg, AS; Strandvik, B	1
Blumer, JL; Kercsmar, CM; Murdell, D; Myers, CM; Reed, MD; Stern, RC	1
Christensen, HO; Høiby, N; Koch, C; Møller, AF; Møller, S; Permin, H	1
Dodge, J; Goodchild, M; Ingram, P; Zamiri, I	1
Fleming, PC; Gold, R; Isles, A; Jin, E; Levison, H	1
Connor, PJ; David, TJ; Phillips, BM	1
Assael, BM; Boccazzi, A; Caccamo, ML; Giunta, A; Marini, A; Padoan, R; Rusconi, F; Sereni, F	1
Cullen, RT; Govan, J; Ingram, TM; McCrae, WM; Raeburn, JA	1
Ingham, HR; Selkon, JB; Snow, MH; Wardle, JK	1
Heilesen, AM; Høiby, N; Koch, C; Permin, H	1
Neu, HC; Scully, BE	1
Cabezudo, I; Guenthner, SH; Selden, RF; Thompson, RL; Wenzel, RP	1
Gold, R; Isles, AF; Leeder, JS; MacLeod, SM; Spino, M; Tesoro, AM	1
Flensborg, EW; Høiby, N; Szaff, M	1
Ackers, I; Blumer, JL; Myers, CM; Reed, MD; Stern, RC; Yamashita, TS	1
Jensen, K; Koch, C; Møller, NE; Vesterhauge, S	1
Alván, G; Arvidsson, A; Strandvik, B	1
Huang, NN; Palmer, JJ; Schidlow, DV	1
Barradell, LB; Bryson, HM	1
Craig, WA	1
Bosso, JA; Huls, CE; Prince, RA; Seilheimer, DK	1
Byrne, S; Connor, P; David, TJ; Dodd, M; Doughty, I; Jenney, M; Maddison, J; Webb, AK	1
Apul'tsina, ID; Avdeev, SN; Chuchalin, AG; Gugutsidze, EN; Kuchkina, NV; Sokolov, AS	1
Bosso, JA; Flume, PA; Friedrich, LV; Manduru, M; Mihm, LB; White, RL	1
Baker, M; Smith, A	1
Brain, JD; Humes, JL; Mumford, RA; Rees, DD; Wohl, ME	1
Bialasiewicz, P; Chudzik, J; Nowak, D; Pietras, T	1
Ghani, M; Soothill, JS	1
Breysem, L; De Boeck, K	1
Belli, DC; Dayer Pastore, F; Dudez, TS; Rochat, T; Schlegel-Haueter, SE; Suter, S	1
Arrouet-Lagande, C; Ategbo, S; Deschildre, A; Druon, D; Husson, MO; Launay, V; Loeuille, GA; Sardet, A; Turck, D; Vic, P	1
Ategbo, S; Canis, F; Husson, MO; Trivier, D; Turck, D; Vic, P	1
Bowler, SD; McCormack, JG; Wolter, JM	1
Bonapace, CR; Bosso, JA; Flume, PA; White, RL	1
Po, AL; Scott, EM; Tariq, VN; Wu, YL	1
Aebischer, CC; Bettinelli, A; Bianchetti, MG; Truttmann, AC; von Vigier, RO; Wermuth, B; Zindler-Schmocker, K	1
Christenson, JC; Daly, JA; Korgenski, EK	1
Cavallo, JD; Fabre, R; Leblanc, F	1
Braggion, C; Cazzola, G; Petrucca, A; Visca, P	1
Bélaz, N; Bille, J; Decosterd, LA; Pilet, M; Rappaz, I; Roulet, M	1
Comes, G; Harms, K; Paul, K; Posselt, HG; Ratjen, F; Wagner, TO	1
Baghurst, PA; Colebatch, KA; Coulthard, KP; Hansman, D; Holmes, M; Jarvinen, A; Kennedy, D; Linke, RJ; Martin, A; Martin, AJ; Master, V; Onishko, CR; Parsons, DW; Roberts, GW; Roberts, ME	1
Baran, D; Byl, B; Herschuelz, A; Jacobs, F; Thys, JP	1
Smyth, A; Walters, S	1
David, TJ; Gore, C	1
Anstead, MI; Craigmyle, J; Kanga, JE; Kuhn, RJ; Robinson, CA	1
Beeg, T; Böhles, H; Gebhardt, B; Posselt, G; Sewell, AC; Solem, E	1
Burns, JL	1
Adam, D	1
Huang, NN	1
Bhakta, DR; Honicky, RE; Jacobson, R; Kumar, A; Leader, I; Robinson-Dunn, B	1
Arguedas, AG; Knupp, CA; Marks, MI; Nussbaum, E; Stutman, HR; Zaleska, M	1
Bosso, JA; Matsen, JM; Saxon, BA	1
Akaniro, JC; Marks, MI; Stutman, HR; Vidaurre, CE	1
Hjelte, L; Malmborg, AS; Strandvik, B	1
McCracken, GH; Mustafa, MM	1
Blumer, JL; Myers, CM; Reed, MD; Stern, RC; Yamashita, TS	1
Borriello, SP; Gaya, H; Peach, SL	1
Aronoff, SC; Klinger, JD	1
Conrad, DA; Marks, MI; Scribner, RK; Weber, AH	1

Reviews

17 review(s) available for cephalosporin c and Cystic Fibrosis of Pancreas

Article	Year
State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics. Pediatric pulmonology, 2020, Volume: 55, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin-Resistant Staphylococcus aureus; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin	2020
Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis. The Cochrane database of systematic reviews, 2021, 06-23, Volume: 6 Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections	2021
Multi-resistant Pseudomonas aeruginosa ST235 in cystic fibrosis. Paediatric respiratory reviews, 2018, Volume: 27 Topics: Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Prognosis; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome	2018
Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. The Cochrane database of systematic reviews, 2014, Apr-30, Issue:4 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Humans; Injections, Intravenous; Randomized Controlled Trials as Topic; Respiratory Tract Infections	2014
Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis. The Cochrane database of systematic reviews, 2016, 12-01, Volume: 12 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Humans; Injections, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiratory Tract Infections	2016
Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management. The Journal of antimicrobial chemotherapy, 2010, Volume: 65, Issue:9 Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cystic Fibrosis; Doripenem; Humans; Minocycline; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus aureus; Stenotrophomonas maltophilia; Tigecycline	2010
Eradication of Pseudomonas aeruginosa in an adult patient with cystic fibrosis. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011, Feb-15, Volume: 68, Issue:4 Topics: Adult; Anti-Infective Agents; Cefepime; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2011
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins. Pediatric pulmonology, 2013, Volume: 48, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefepime; Ceftazidime; Cephalosporins; Clavulanic Acids; Cystic Fibrosis; Disease Progression; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin	2013
Is there a rationale for the continuous infusion of cefepime? A multidisciplinary approach. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:5 Topics: Bacterial Infections; Cefepime; Cephalosporins; Clinical Trials as Topic; Cystic Fibrosis; Drug Administration Schedule; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Treatment Outcome	2003
Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. The Cochrane database of systematic reviews, 2005, Apr-18, Issue:2 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Humans; Injections, Intravenous; Randomized Controlled Trials as Topic; Respiratory Tract Infections	2005
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:9 Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchopneumonia; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Inhalation; Injections, Intravenous; Lung Diseases; Pneumonia, Bacterial; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2005
Antibiotics in pediatric respiratory diseases. Clinics in chest medicine, 1980, Volume: 1, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Child; Chloramphenicol; Cystic Fibrosis; Empyema; Humans; Legionnaires' Disease; Lung Abscess; Penicillins; Pneumonia; Respiratory Tract Infections; Sulfamethoxazole; Tetracyclines; Trimethoprim	1980
Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs, 1994, Volume: 47, Issue:3 Topics: Aging; Animals; Bacteria; Bacterial Infections; Cefepime; Cephalosporins; Clinical Trials as Topic; Cystic Fibrosis; Drug Administration Schedule; Humans; Microbial Sensitivity Tests; Renal Insufficiency	1994
The pharmacokinetics of cefpirome--rationale for a twelve-hour dosing regimen. Scandinavian journal of infectious diseases. Supplementum, 1993, Volume: 91 Topics: Adult; Age Factors; Aged; Bacteria; Cefpirome; Cephalosporins; Cystic Fibrosis; Drug Administration Routes; Drug Administration Schedule; Humans; Infections; Kidney Diseases; Liver Diseases; Middle Aged	1993
Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. The Cochrane database of systematic reviews, 2001, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Humans; Injections, Intravenous; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Respiratory Tract Infections	2001
Antimicrobial agents in pediatrics. Infectious disease clinics of North America, 1989, Volume: 3, Issue:3 Topics: Adolescent; Adult; Age Factors; Anti-Bacterial Agents; Aztreonam; Cephalosporins; Child; Child, Preschool; Cilastatin; Cystic Fibrosis; Humans; Imipenem; Infant; Tissue Distribution	1989
Cephalosporin therapeutics in cystic fibrosis. The Journal of pediatrics, 1986, Volume: 108, Issue:5 Pt 2 Topics: Cefsulodin; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Cystic Fibrosis; Humans; Kinetics; Lung Diseases; Pseudomonas Infections; Structure-Activity Relationship	1986

Trials

22 trial(s) available for cephalosporin c and Cystic Fibrosis of Pancreas

Article	Year
Plasma pharmacokinetics of ceftolozane/tazobactam in pediatric patients with cystic fibrosis. Pediatric pulmonology, 2020, Volume: 55, Issue:8 Topics: Administration, Intravenous; Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Female; Gram-Negative Bacterial Infections; Humans; Male; Tazobactam	2020
Pharmacokinetic and Pharmacodynamic Analyses of Ceftaroline in Adults with Cystic Fibrosis. Pharmacotherapy, 2016, Volume: 36, Issue:1 Topics: Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cystic Fibrosis; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Young Adult	2016
Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted with Acute Pulmonary Exacerbation. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11 Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Female; Humans; Infusions, Intravenous; Lung; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Patient Safety; Penicillanic Acid; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Tazobactam	2016
Inhalation with fucose and galactose for treatment of Pseudomonas aeruginosa in cystic fibrosis patients. International journal of medical sciences, 2008, Volume: 5, Issue:6 Topics: Administration, Inhalation; Adult; Aminoglycosides; C-Reactive Protein; Cell Count; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Female; Fucose; Galactose; Gene Expression; Humans; Immunoglobulin Isotypes; Leukocytes, Mononuclear; Liver Function Tests; Male; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Function Tests; Sputum; Treatment Outcome; Tumor Necrosis Factor-alpha	2008
Pilot study of continuous infusion cefepime in adult patients with cystic fibrosis. The Journal of antimicrobial chemotherapy, 2006, Volume: 57, Issue:5 Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cystic Fibrosis; Humans; Infusions, Intravenous; Metabolic Clearance Rate; Pilot Projects; Time Factors	2006
Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Alcohol Deterrents; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Cephalosporins; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Eosinophilia; Humans; Moxalactam; Penicillins; Piperacillin; Pseudomonas Infections; Random Allocation; Respiratory Tract Infections	1983
Ceftazidime in treatment of acute pulmonary exacerbations in patients with cystic fibrosis. The Journal of pediatrics, 1983, Volume: 103, Issue:2 Topics: Acute Disease; Adolescent; Ceftazidime; Cephalosporins; Child; Clinical Trials as Topic; Cystic Fibrosis; Female; Humans; Kinetics; Lung Diseases; Male; Pseudomonas Infections	1983
Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Adult; Carbenicillin; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Penicillin Resistance; Prospective Studies; Pseudomonas Infections; Random Allocation; Respiratory Function Tests; Respiratory Tract Infections; Tobramycin	1983
Cefsulodin sodium therapy in cystic fibrosis patients. Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:1 Topics: Adolescent; Adult; Cefsulodin; Cephalosporins; Clinical Trials as Topic; Cystic Fibrosis; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum	1984
Pharmacokinetics of cefepime in cystic fibrosis patients. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:7 Topics: Adolescent; Adult; Cefepime; Cephalosporins; Child; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged	1993
Clinical evaluation of meropenem versus ceftazidime for the treatment of Pseudomonas spp. infections in cystic fibrosis patients. The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A Topics: Adolescent; Adult; Carbapenems; Ceftazidime; Cephalosporins; Child, Preschool; Cystic Fibrosis; Drug Tolerance; Humans; Liver; Meropenem; Microbial Sensitivity Tests; Nausea; Pseudomonas Infections; Spirometry; Sputum; Thienamycins; Transaminases; Treatment Outcome; Vomiting	1995
[Treatment of patients with pneumonia, chronic obstructive bronchitis and mucoviscidosis with cefpirome]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1996, Volume: 41, Issue:12 Topics: Adolescent; Adult; Aged; Bacterial Infections; Bronchitis; Cefpirome; Cephalosporins; Chronic Disease; Cystic Fibrosis; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus; Treatment Outcome	1996
Cefsulodin chocolate blood agar: a selective medium for the recovery of Haemophilus influenzae from the respiratory secretions of patients with cystic fibrosis. Journal of medical microbiology, 1997, Volume: 46, Issue:10 Topics: Agar; Bacitracin; Blood; Cacao; Cefsulodin; Cephalosporins; Culture Media; Cystic Fibrosis; Haemophilus Infections; Haemophilus influenzae; Hemin; Humans; Inhalation; Respiratory Tract Infections; Sputum	1997
Treatment of Pseudomonas aeruginosa lung infection in cystic fibrosis with high or conventional doses of ceftazidime. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3 Topics: Adolescent; Alanine Transaminase; Blood Sedimentation; Body Weight; Ceftazidime; Cephalosporins; Child; Creatinine; Cystic Fibrosis; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Hemoglobins; Humans; Leukocyte Count; Lung; Lung Diseases; Lung Volume Measurements; Male; Neutrophils; Patient Readmission; Platelet Count; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Ventilation; Recurrence; Respiratory Function Tests; Time Factors; Treatment Outcome; Veins; Vital Capacity	1998
Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis. Archives of disease in childhood, 1998, Volume: 78, Issue:6 Topics: Adolescent; Adult; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Pseudomonas Infections; Sputum; Statistics, Nonparametric; Tobramycin	1998
[Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis]. Pathologie-biologie, 1998, Volume: 46, Issue:6 Topics: Adolescent; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Administration Schedule; Drug Therapy, Combination; Humans; Pneumonia, Bacterial; Pseudomonas Infections; Tobramycin	1998
Are antipseudomonal antibiotics really beneficial in acute respiratory exacerbations of cystic fibrosis? Australian and New Zealand journal of medicine, 1999, Volume: 29, Issue:1 Topics: Acute Disease; Adult; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tobramycin	1999
A pilot study of the efficacy of constant-infusion ceftazidime in the treatment of endobronchial infections in adults with cystic fibrosis. Pharmacotherapy, 1999, Volume: 19, Issue:5 Topics: Adult; Bronchial Diseases; Ceftazidime; Cephalosporins; Cross-Over Studies; Cystic Fibrosis; Female; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Pilot Projects; Prospective Studies; Pseudomonas aeruginosa; Respiratory Function Tests; Respiratory Tract Infections	1999
Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study. Pediatric pulmonology, 2001, Volume: 31, Issue:5 Topics: Adolescent; Adult; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Cystic Fibrosis; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Pseudomonas Infections; Respiratory Function Tests; Respiratory Tract Infections; Time Factors; Tobramycin; Treatment Outcome	2001
Cefepime. Pharmacokinetics and clinical response in patients with cystic fibrosis. American journal of diseases of children (1960), 1992, Volume: 146, Issue:7 Topics: Adolescent; Adult; California; Cefepime; Cephalosporins; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Female; Hospitals, Pediatric; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Microbial Sensitivity Tests; Respiratory Tract Infections; Severity of Illness Index; Sputum; Tissue Distribution; Vital Capacity	1992
Cephalosporin therapeutics in cystic fibrosis. The Journal of pediatrics, 1986, Volume: 108, Issue:5 Pt 2 Topics: Cefsulodin; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Cystic Fibrosis; Humans; Kinetics; Lung Diseases; Pseudomonas Infections; Structure-Activity Relationship	1986
Comparison of cefpiramide (HR-810) and four anti-pseudomonal beta-lactam agents against pseudomonas isolates from children with cystic fibrosis. The Journal of antimicrobial chemotherapy, 1985, Volume: 15, Issue:5 Topics: Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Pseudomonas; Pseudomonas aeruginosa; Sputum; Tobramycin	1985

Other Studies

92 other study(ies) available for cephalosporin c and Cystic Fibrosis of Pancreas

Article	Year
Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults. Journal of global antimicrobial resistance, 2022, Volume: 28 Topics: Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cohort Studies; Cystic Fibrosis; Humans; Lung; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin	2022
Longitudinal Evolution of the Pseudomonas-Derived Cephalosporinase (PDC) Structure and Activity in a Cystic Fibrosis Patient Treated with β-Lactams. mBio, 2022, 10-26, Volume: 13, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Cephalosporinase; Cephalosporins; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections	2022
Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023, Volume: 29, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactamases; Cefiderocol; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Genomics; Humans; Iron; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2023
Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Cefiderocol, and Novel Darobactin Analogs against Multidrug-Resistant Pseudomonas aeruginosa Isolates from Pediatric and Adolescent Cystic Fibrosis Patients. Microbiology spectrum, 2023, 02-14, Volume: 11, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Child; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
Antimicrobial resistance of Pseudomonas aeruginosa in a cystic fibrosis population after introduction of a novel cephalosporin/β-lactamase inhibitor combination. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2023, Volume: 131, Issue:8 Topics: Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporinase; Cephalosporins; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Monobactams; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
Antimicrobial susceptibility of ceftolozane-tazobactam against multidrug-resistant Pseudomonas aeruginosa isolates from Melbourne, Australia. Pathology, 2023, Volume: 55, Issue:5 Topics: Adult; Anti-Bacterial Agents; Australia; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2023
Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2020, 01-01, Volume: 75, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; Biofilms; Cephalosporins; Cystic Fibrosis; Drug Synergism; Humans; Microbial Sensitivity Tests; Middle Aged; Nitric Oxide Donors; Prodrugs; Pseudomonas aeruginosa; Pseudomonas Infections; Young Adult	2020
Discovery of Cephalosporin-3'-Diazeniumdiolates That Show Dual Antibacterial and Antibiofilm Effects against ACS infectious diseases, 2020, 06-12, Volume: 6, Issue:6 Topics: Adult; Animals; Anti-Bacterial Agents; Azo Compounds; Biofilms; Cephalosporins; Cystic Fibrosis; Humans; Mice; Pseudomonas aeruginosa; Respiratory Tract Infections	2020
Combining bacteriophages with cefiderocol and meropenem/vaborbactam to treat a pan-drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient. Pediatric pulmonology, 2020, Volume: 55, Issue:11 Topics: Achromobacter; Anti-Bacterial Agents; Bacteriophages; Boronic Acids; Cefiderocol; Cephalosporins; Child; Combined Modality Therapy; Cystic Fibrosis; Drug Combinations; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Gram-Negative Bacterial Infections; Heterocyclic Compounds, 1-Ring; Humans; Meropenem	2020
Ceftaroline vs vancomycin for the treatment of acute pulmonary exacerbations in pediatric patients with cystic fibrosis. Pediatric pulmonology, 2020, Volume: 55, Issue:12 Topics: Administration, Intravenous; Adolescent; Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Infant; Infant, Newborn; Male; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin; Young Adult	2020
Carbapenems drive the collateral resistance to ceftaroline in cystic fibrosis patients with MRSA. Communications biology, 2020, 10-22, Volume: 3, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Ceftaroline; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Genome, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Staphylococcal Infections	2020
In vitro activity of ceftolozane-tazobactam and ceftazidime-avibactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis. Diagnostic microbiology and infectious disease, 2021, Volume: 99, Issue:2 Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Tazobactam	2021
Cefiderocol for the Treatment of Adult and Pediatric Patients With Cystic Fibrosis and Achromobacter xylosoxidans Infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 10-05, Volume: 73, Issue:7 Topics: Achromobacter denitrificans; Adult; Anti-Bacterial Agents; Cefiderocol; Cephalosporins; Child; Cystic Fibrosis; Gram-Negative Bacterial Infections; Humans	2021
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. Cephalosporins and penicillins latest update. Pediatric pulmonology, 2021, Volume: 56, Issue:6 Topics: Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Humans; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections	2021
Ceftolozane/tazobactam for Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis adult patients: a case series. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021, Volume: 40, Issue:10 Topics: Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Humans; Italy; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tazobactam; Young Adult	2021
Trends of Antimicrobial Resistance and Combination Susceptibility Testing of Multidrug-Resistant Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients: a 10-Year Update. Antimicrobial agents and chemotherapy, 2021, 05-18, Volume: 65, Issue:6 Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2021
Enabling antibiotic allergy evaluations and reintroduction of first-line antibiotics for patients with cystic fibrosis. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2021, Volume: 127, Issue:4 Topics: Adult; Anti-Bacterial Agents; Antimicrobial Stewardship; Cephalosporins; Cystic Fibrosis; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulfonamides; Young Adult	2021
Optimization of antibiotics for cystic fibrosis pulmonary exacerbations due to highly resistant nonlactose fermenting Gram negative bacilli: Meropenem-vaborbactam and cefiderocol. Pediatric pulmonology, 2021, Volume: 56, Issue:9 Topics: Anti-Bacterial Agents; Boronic Acids; Cefiderocol; Cephalosporins; Child; Cystic Fibrosis; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Meropenem	2021
Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients. Pediatric pulmonology, 2017, Volume: 52, Issue:8 Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Female; Hospitalization; Humans; Incidence; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Tobramycin; Vancomycin	2017
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. Cephalosporins and penicillins update. Pediatric pulmonology, 2017, Volume: 52, Issue:7 Topics: Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Humans; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections	2017
Multifocal fixed drug eruption to ceftazidime in a child with cystic fibrosis. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2018, Volume: 29, Issue:1 Topics: Ceftazidime; Cephalosporins; Child; Cystic Fibrosis; Drug Eruptions; Female; Histamine Antagonists; Humans; Skin	2018
Ceftaroline pharmacokinetics and pharmacodynamics in patients with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2018, Volume: 17, Issue:3 Topics: Adolescent; Adult; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Child; Chromatography, Liquid; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Monitoring; Female; Half-Life; Humans; Male; Mass Spectrometry; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prospective Studies; Treatment Outcome	2018
In vitro antimicrobial activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and other non-fermenting Gram-negative bacteria in adults with cystic fibrosis. Journal of global antimicrobial resistance, 2018, Volume: 14 Topics: Achromobacter denitrificans; Adult; beta-Lactamase Inhibitors; Burkholderia cenocepacia; Cephalosporins; Colistin; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Sputum; Stenotrophomonas maltophilia; Tazobactam	2018
Ceftolozane/tazobactam sensitivity patterns in Pseudomonas aeruginosa isolates recovered from sputum of cystic fibrosis patients. Diagnostic microbiology and infectious disease, 2018, Volume: 92, Issue:1 Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Tazobactam	2018
Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:9 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Burkholderia cepacia complex; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Humans; Microbial Sensitivity Tests; Sulfamethoxazole; Tazobactam; Trimethoprim	2018
In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients. The Journal of antimicrobial chemotherapy, 2019, 02-01, Volume: 74, Issue:2 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactams; Burkholderia cepacia complex; Burkholderia gladioli; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Tazobactam	2019
Evaluation of in vitro activity of ceftolozane-tazobactam compared to other antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients. Diagnostic microbiology and infectious disease, 2019, Volume: 94, Issue:3 Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Infant; Infant, Newborn; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Young Adult	2019
Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients. International journal of antimicrobial agents, 2019, Volume: 53, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin, Tazobactam Drug Combination; Porins; Pseudomonas aeruginosa; Pseudomonas Infections; Scotland; Tazobactam; Whole Genome Sequencing	2019
Comment on: In vitro activity of seven β-lactams including ceftolozane/tazobactam and ceftazidime/avibactam against Burkholderia cepacia complex, Burkholderia gladioli and other non-fermentative Gram-negative bacilli isolated from cystic fibrosis patients The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10 Topics: Azabicyclo Compounds; Burkholderia cepacia complex; Burkholderia gladioli; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Humans; Tazobactam	2019
Use of continuous infusion ceftolozane-tazobactam with therapeutic drug monitoring in a patient with cystic fibrosis. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2019, Apr-08, Volume: 76, Issue:8 Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Drug Administration Schedule; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infusions, Intravenous; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome	2019
PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11 Topics: Adult; Amino Acid Substitution; Anti-Bacterial Agents; Base Sequence; Binding Sites; Ceftaroline; Cephalosporins; Cystic Fibrosis; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; MutS DNA Mismatch-Binding Protein; Penicillin-Binding Proteins; Sequence Analysis, DNA; Staphylococcal Infections; Young Adult	2014
Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic Exposure. The Pediatric infectious disease journal, 2016, Volume: 35, Issue:7 Topics: Anti-Bacterial Agents; Base Sequence; Cephalosporins; Child, Preschool; Cystic Fibrosis; DNA, Bacterial; Drug Resistance, Bacterial; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Staphylococcal Infections	2016
Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosa. Pharmacotherapy, 2016, Volume: 36, Issue:10 Topics: Adult; Anti-Bacterial Agents; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Treatment Outcome	2016
Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11 Topics: Aminoglycosides; Anti-Bacterial Agents; Belgium; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Gene Expression; Germany; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; United Kingdom	2016
Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4 Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; Tazobactam; Thienamycins	2017
Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:4 Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Biofilms; Cefepime; Cephalosporins; Ciprofloxacin; Cystic Fibrosis; DNA-Binding Proteins; Humans; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; MutS DNA Mismatch-Binding Protein; Pseudomonas aeruginosa; Transcription Factors	2009
The in-vitro activity of three anti-pseudomonal cephalosporins against isolates from patients with cystic fibrosis. The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl B Topics: Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Resistance, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus	1981
Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Spain	2010
Comparable population pharmacokinetics and pharmacodynamic breakpoints of cefpirome in cystic fibrosis patients and healthy volunteers. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:6 Topics: Adolescent; Adult; Anti-Bacterial Agents; Body Size; Cefpirome; Cephalosporins; Cystic Fibrosis; Female; Humans; Male; Microbial Sensitivity Tests; Monte Carlo Method	2011
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:3 Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Critical Care; Cystic Fibrosis; Data Collection; Drug Resistance, Bacterial; Europe; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Population Surveillance; Proteus Infections; Proteus mirabilis; Tazobactam; Thienamycins	2002
Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units). Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:8 Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Critical Care; Cystic Fibrosis; Drug Stability; Drug Storage; Humans; Hydrogen-Ion Concentration; Infusion Pumps; Pseudomonas Infections; Pyridines; Syringes; Temperature	2002
Stability and compatibility study of cefepime in comparison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units. The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:3 Topics: Ambulatory Care; Cefepime; Ceftazidime; Cephalosporins; Chemical Precipitation; Cystic Fibrosis; Drug Incompatibility; Drug Stability; Drug Storage; Drug Therapy, Combination; Infusions, Intravenous; Intensive Care Units	2003
[Evaluation of a E-test method to detect bactericidy of beta lactam-aminoglycoside associations against Pseudomonas aeruginosa isolates from cystic fibrosis]. Pathologie-biologie, 2003, Volume: 51, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	2003
Lack of efflux mechanism in a clinical isolate of Pseudomonas aeruginosa highly resistant to beta-lactams and imipenem. Folia microbiologica, 2003, Volume: 48, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Biological Transport, Active; Cefepime; Ceftazidime; Ceftriaxone; Cell Membrane Permeability; Cephalosporins; Conjugation, Genetic; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Electrophoresis, Polyacrylamide Gel; Genes, Bacterial; Humans; Imipenem; Membrane Transport Proteins; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa	2003
Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2005, Volume: 4, Issue:1 Topics: Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Cystic Fibrosis; Female; Humans; Length of Stay; Male; Methicillin; Methicillin Resistance; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus	2005
[Efficacy and safety of cefepime in the treatment of bronchopulmonary disease exacerbation in pediatric patients with mucoviscidosis]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2005, Volume: 50, Issue:4 Topics: Adolescent; Anti-Bacterial Agents; Bronchial Diseases; Cefepime; Cephalosporins; Child; Cystic Fibrosis; Female; Humans; Lung Diseases; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum; Staphylococcal Infections; Staphylococcus aureus	2005
Interaction between moxalactam and alcohol. Lancet (London, England), 1980, Jun-28, Volume: 1, Issue:8183 Topics: Adolescent; Adult; Blood Pressure; Cephalosporins; Cephamycins; Cystic Fibrosis; Drug Interactions; Ethanol; Female; Humans; Male; Moxalactam; Vomiting	1980
Ceftazidime in cystic fibrosis. Lancet (London, England), 1982, Jun-12, Volume: 1, Issue:8285 Topics: Adolescent; Adult; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Infant; Lung Diseases; Male	1982
Moxalactam-tobramycin-resistant Pseudomonas aeruginosa isolates in patients with cystic fibrosis. Clinical pediatrics, 1983, Volume: 22, Issue:9 Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Child; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Male; Moxalactam; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tobramycin	1983
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Antimicrobial agents and chemotherapy, 1981, Volume: 20, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections	1981
Ceftazidime therapy for serious infections. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Male; Middle Aged; Peritonitis; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Urinary Tract Infections	1983
Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Adult; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Half-Life; Humans; Kinetics; Pseudomonas Infections; Respiratory Tract Infections; Sputum; Tobramycin	1983
Ceftazidime in cystic fibrosis: pharmacokinetics and therapeutic response. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Adult; Ceftazidime; Cephalosporins; Child; Cystic Fibrosis; Female; Humans; Kinetics; Male; Premedication; Probenecid; Pseudomonas Infections; Respiratory Tract Infections	1983
Experience with ceftazidime in cystic fibrosis. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Male; Pseudomonas Infections; Respiratory Tract Infections	1983
Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Piperacillin; Pseudomonas Infections; Respiratory Tract Infections; Sulfamethoxazole; Tobramycin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	1983
Ceftazidime - a significant advance in the treatment of cystic fibrosis. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Adult; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Floxacillin; Humans; Male; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Tobramycin	1983
Clinical pharmacology of ceftazidime in paediatrics. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Ceftazidime; Cephalosporins; Child, Preschool; Cystic Fibrosis; Female; Half-Life; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kinetics; Male; Microbial Sensitivity Tests; Pseudomonas Infections; Respiratory Tract Infections; Tissue Distribution; Urinary Tract Infections	1983
Ceftazidime in cystic fibrosis: clinical, microbiological and immunological studies. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adolescent; Adult; Ceftazidime; Cephalosporins; Child; Cystic Fibrosis; Female; Humans; Male; Neutrophils; Pseudomonas Infections; Recurrence; Respiratory Tract Infections	1983
An open study of the use of ceftazidime in Gram-negative infections. The Journal of antimicrobial chemotherapy, 1983, Volume: 12 Suppl A Topics: Adult; Aged; Ceftazidime; Cephalosporins; Cystic Fibrosis; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Middle Aged; Osteomyelitis; Pseudomonas Infections; Respiratory Tract Infections; Urinary Tract Infections; Wound Infection	1983
Treatment of chronic pseudomonas aeruginosa infection in cystic fibrosis patients with ceftazidime and tobramycin. Scandinavian journal of infectious diseases, 1983, Volume: 15, Issue:3 Topics: Adolescent; Adult; Ceftazidime; Cephalosporins; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	1983
Clinical efficacy of ceftazidime. Treatment of serious infection due to multiresistant Pseudomonas and other gram-negative bacteria. Archives of internal medicine, 1984, Volume: 144, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Evaluation; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Humans; Infant; Lung Diseases; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Urinary Tract Infections	1984
Ceftazidime disposition in acute and stable cystic fibrosis. Clinical pharmacology and therapeutics, 1984, Volume: 36, Issue:3 Topics: Adolescent; Adult; Ceftazidime; Cephalosporins; Cystic Fibrosis; Female; Half-Life; Humans; Injections, Intravenous; Kinetics; Lung Diseases; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum	1984
Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta paediatrica Scandinavica, 1983, Volume: 72, Issue:5 Topics: Adult; Anti-Bacterial Agents; Carbenicillin; Cefsulodin; Cephalosporins; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Peak Expiratory Flow Rate; Pseudomonas Infections; Tobramycin	1983
Single-dose pharmacokinetics of cefsulodin in patients with cystic fibrosis. Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:5 Topics: Adolescent; Adult; Cefsulodin; Cephalosporins; Child; Cystic Fibrosis; Female; Humans; Injections, Intravenous; Kinetics; Male	1984
Treatment of pulmonary Pseudomonas aeruginosa infection in cystic fibrosis with cefsulodin. Scandinavian journal of infectious diseases, 1982, Volume: 14, Issue:3 Topics: Adolescent; Adult; Cefsulodin; Cephalosporins; Child; Cystic Fibrosis; Drug Evaluation; Female; Humans; Lung Diseases; Male; Pseudomonas aeruginosa; Pseudomonas Infections	1982
Difference in renal handling of cefsulodin between patients with cystic fibrosis and normal subjects. Acta paediatrica Scandinavica, 1983, Volume: 72, Issue:2 Topics: Adolescent; Adult; Cefsulodin; Cephalosporins; Cystic Fibrosis; Female; Glomerular Filtration Rate; Humans; Inulin; Kidney; Male	1983
In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:9 Topics: Ceftazidime; Cephalosporins; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	1997
Inhibition of neutrophil elastase in CF sputum by L-658,758. The Journal of pharmacology and experimental therapeutics, 1997, Volume: 283, Issue:3 Topics: Adult; Animals; Cephalosporins; Cystic Fibrosis; Humans; Leukocyte Elastase; Mice; Serine Proteinase Inhibitors; Sputum	1997
Severe haemorrhagic diathesis in an adult patient with cystic fibrosis after long-term antibiotic treatment of pulmonary infection. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 1997, Volume: 52, Issue:4 Topics: Adult; Cefuroxime; Cephalosporins; Cystic Fibrosis; Follow-Up Studies; Gentamicins; Hemorrhagic Disorders; Humans; Male; Netilmicin; Pneumonia; Time Factors; Vitamin K	1997
Ceftazidime, gentamicin, and rifampicin, in combination, kill biofilms of mucoid Pseudomonas aeruginosa. Canadian journal of microbiology, 1997, Volume: 43, Issue:11 Topics: Anti-Bacterial Agents; Biofilms; Bronchi; Ceftazidime; Cephalosporins; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Polysaccharides, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Rifampin; Time Factors	1997
Chemotactic factors in bronchial secretions of cystic fibrosis patients. The Journal of infectious diseases, 1998, Volume: 177, Issue:5 Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Bronchi; Bronchoalveolar Lavage Fluid; Cephalosporins; Chemotactic Factors; Chemotaxis, Leukocyte; Child; Chromatography, Gel; Cystic Fibrosis; Drug Therapy, Combination; Humans; Middle Aged; Pseudomonas Infections; Sputum	1998
Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1999, Volume: 107, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azlocillin; Ceftazidime; Cephalosporins; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin	1999
Aminoglycosides and renal magnesium homeostasis in humans. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2000, Volume: 15, Issue:6 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Cystic Fibrosis; Drug Therapy, Combination; Electrolytes; Female; Homeostasis; Humans; Kidney; Lung Diseases; Magnesium; Male; Pseudomonas aeruginosa; Pseudomonas Infections	2000
In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients. The Journal of antimicrobial chemotherapy, 2000, Volume: 45, Issue:6 Topics: Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins	2000
[Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study]. Pathologie-biologie, 2000, Volume: 48, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporinase; Cephalosporins; Cystic Fibrosis; France; Humans; Microbial Sensitivity Tests; Penicillins; Prospective Studies; Pseudomonas aeruginosa; Serotyping; Ticarcillin	2000
Travel-associated Burkholderia pseudomallei infection (Melioidosis) in a patient with cystic fibrosis: a case report. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Volume: 32, Issue:1 Topics: Anti-Bacterial Agents; Burkholderia pseudomallei; Ceftazidime; Cephalosporins; Cystic Fibrosis; DNA, Bacterial; Drug Therapy, Combination; Female; Humans; Melioidosis; Molecular Sequence Data; Risk Factors; RNA, Ribosomal, 16S; Thailand; Travel; Trimethoprim, Sulfamethoxazole Drug Combination	2001
Continuous infusion of ceftazidime with a portable pump is as effective as thrice-a-day bolus in cystic fibrosis children. European journal of pediatrics, 2000, Volume: 159, Issue:12 Topics: Adolescent; Ceftazidime; Cephalosporins; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Female; Humans; Infusion Pumps; Male; Microbial Sensitivity Tests; Nutritional Status; Pseudomonas Infections	2000
Effect of continuous antistaphylococcal therapy on the rate of P. aeruginosa acquisition in patients with cystic fibrosis. Pediatric pulmonology, 2001, Volume: 31, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; Body Mass Index; Cephalosporins; Chemoprevention; Child; Child, Preschool; Cystic Fibrosis; Databases as Topic; Forced Expiratory Volume; Humans; Infant; Lung; Macrolides; Pseudomonas aeruginosa; Pseudomonas Infections; Registries; Staphylococcal Infections; Staphylococcus aureus; Statistics, Nonparametric; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vital Capacity	2001
Serum pharmacokinetics and sputum penetration of amikacin 30 mg/kg once daily and of ceftazidime 200 mg/kg/day as a continuous infusion in cystic fibrosis patients. The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:2 Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Child; Cystic Fibrosis; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Sputum	2001
CF and antistaphylococcal prophylaxis. Thorax, 2001, Volume: 56, Issue:10 Topics: Cephalexin; Cephalosporins; Child; Cystic Fibrosis; Humans; Infant; Pseudomonas Infections; Staphylococcal Infections	2001
Drug-induced fever and bone marrow suppression in a 12-year-old girl with cystic fibrosis. Journal of the Royal Society of Medicine, 2001, Volume: 94 Suppl 40 Topics: Bone Marrow Diseases; Ceftazidime; Cephalosporins; Child; Cystic Fibrosis; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Fever; Humans	2001
Susceptibility of pseudomonas aeruginosa to cefepime versus ceftazidime in patients with cystic fibrosis. Pharmacotherapy, 2001, Volume: 21, Issue:11 Topics: Adolescent; Adult; Cefepime; Ceftazidime; Cephalosporins; Chi-Square Distribution; Child; Child, Preschool; Cystic Fibrosis; Drug Resistance, Bacterial; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pseudomonas aeruginosa	2001
Antibiotic treatment-induced tubular dysfunction as a risk factor for renal stone formation in cystic fibrosis. The Journal of pediatrics, 2002, Volume: 140, Issue:1 Topics: Adolescent; Adult; Anti-Infective Agents; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Kidney Calculi; Kidney Tubules; Male; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination	2002
Emergence of new pathogens in CF: the devil we know or the devil we don't know? The Journal of pediatrics, 2002, Volume: 140, Issue:3 Topics: Antibiotic Prophylaxis; Cephalexin; Cephalosporins; Cystic Fibrosis; Humans; Opportunistic Infections; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas Infections	2002
[Therapy of chronic respiratory tract infections in children, including mucoviscidosis (author's transl)]. Infection, 1979, Volume: 7 Suppl 6 Topics: Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Drug Combinations; Humans; Infant; Infant, Newborn; Long-Term Care; Pseudomonas Infections; Recurrence; Respiratory Tract Infections; Staphylococcal Infections; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination	1979
The use of new antibiotic agents for chronic pulmonary disease. Pediatric annals, 1978, Volume: 7, Issue:1 Topics: Agammaglobulinemia; Aminoglycosides; Anti-Bacterial Agents; Asthma; Bacterial Infections; Cephalosporins; Chronic Disease; Cystic Fibrosis; Immunologic Deficiency Syndromes; Penicillins; Pneumonia, Aspiration; Respiratory Tract Infections; Sulfamethoxazole; Tetracyclines; Trimethoprim	1978
Antibacterial properties of investigational, new, and commonly used antibiotics against isolates of Pseudomonas cepacia in Michigan. Chemotherapy, 1992, Volume: 38, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Burkholderia cepacia; Cephalosporins; Cystic Fibrosis; Drugs, Investigational; Fluoroquinolones; Humans; Michigan; Microbial Sensitivity Tests; Sputum	1992
Comparative activity of cefepime, alone and in combination, against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patients. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:4 Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa; Sputum	1991
In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputum. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:7 Topics: Bacteria; Cephalosporins; Cystic Fibrosis; Kinetics; Microbial Sensitivity Tests; Sputum	1990
Serum and sputum concentrations of netilmicin in combination with acylureidopenicillin and cephalosporins in clinical treatment of pulmonary exacerbations in cystic fibrosis. The Journal of antimicrobial chemotherapy, 1989, Volume: 23, Issue:6 Topics: Adolescent; Adult; Azlocillin; Cephalosporins; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Lung Diseases; Male; Netilmicin; Pseudomonas aeruginosa; Sputum	1989
Faecal carriage of Clostridium difficile in cystic fibrosis patients. Annali dell'Istituto superiore di sanita, 1986, Volume: 22, Issue:3 Topics: Adolescent; Adult; Aged; Cephalosporins; Child; Clostridium; Clostridium Infections; Cystic Fibrosis; Feces; Humans; Middle Aged	1986
In vitro activity of BMY-28142 against pediatric pathogens, including isolates from cystic fibrosis sputum. Antimicrobial agents and chemotherapy, 1985, Volume: 28, Issue:1 Topics: Bacteria; Cefepime; Cephalosporins; Child; Cystic Fibrosis; Drug Interactions; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sputum; Staphylococcus aureus; Streptococcus pneumoniae	1985